Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes.
about
Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcriptionMechanisms underlying inflammation in neurodegenerationBrain aging and AD-like pathology in streptozotocin-induced diabetic rats.GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseAdiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicityExendin-4 antagonizes Aβ1-42-induced attenuation of spatial learning and memory abilityExperimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsMammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathologyOxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferMidlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.Protective role of curcumin on colchicine-induced cognitive dysfunction and oxidative stress in rats.Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus
P2860
Q28570400-32E9D18C-6DB0-49CA-8241-D987D9B6943FQ29617977-B714EFA7-3591-4341-A1B4-2062D4E3F86CQ34114295-BFB5A46B-BAF5-4E4F-B00A-4BF4784CA801Q34167980-9E60D77D-8EC6-4C86-9DE8-556E6750CEFBQ34533985-F8751C0A-79EA-4D50-AF48-4CEC13BE71BEQ34540588-69FC9141-4056-4DD8-8D0C-1482FEE4E0AEQ37406399-9C7F7B57-236C-4BE2-811B-5E847F3AAD97Q37615991-603AEA7C-C186-4D21-A66A-6EE781ACAA6FQ37680075-365A0407-C620-4E77-A59D-2CBC4F7D22C5Q40683231-2856AB6C-3250-439A-A24A-E9C69CCC9ED5Q41847084-8BC9328C-8281-4173-AEDC-5BA17D1EBB0AQ45254835-96D9E84A-6250-4E9F-AD78-DC741236EB5FQ47703267-6D0985E5-BD7C-497D-A898-0F44DB3B285BQ48701908-09515497-D422-4EEB-BC5E-69AE19859CBCQ58702626-8548D4D9-A65F-4120-BF9E-6517339B0E68
P2860
Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common pathological processes ...... s disease and type 2 diabetes.
@en
Common pathological processes ...... s disease and type 2 diabetes.
@nl
type
label
Common pathological processes ...... s disease and type 2 diabetes.
@en
Common pathological processes ...... s disease and type 2 diabetes.
@nl
prefLabel
Common pathological processes ...... s disease and type 2 diabetes.
@en
Common pathological processes ...... s disease and type 2 diabetes.
@nl
P2093
P356
P1476
Common pathological processes ...... s disease and type 2 diabetes.
@en
P2093
Allan Jones
Anke Ostertag
Philipp Kulozik
P304
P356
10.3233/JAD-2009-0973
P577
2009-01-01T00:00:00Z